Skip to content
GLP-1 Decoder

Liraglutide for Seniors: Evidence, Eligibility, Coverage

Liraglutide has no separate rule for adults 65 and older. It is approved for type 2 diabetes and heart risk.

Brands
Victoza and Saxenda

Saxenda key facts

How long the body keeps it
100%50%25%0%013 h26 h39 h2.2 d2.7 d50%25%12.5%time after the dose

Its half-life is about 13 hours: after 13 h, half remains, and after five half-lives (2.7 d), about 3% is left.

Main trial weight loss result
Saxenda (SCALE Obesity and Prediabetes)7.4%Placebo3%

During the SCALE Obesity and Prediabetes, 56 weeks trial, weight loss reached 7.4%, compared with 3% on placebo.

Warning information is in the FDA label (DailyMed).

Who qualifies?

Liraglutide: who qualifies
MedicineWho qualifies
VictozaThis medicine lowers blood sugar for adults and children 10 and older with type 2 diabetes, when used with diet and exercise.
VictozaWhen an adult has both type 2 diabetes and heart disease, the risk of heart-related death, stroke and heart attack goes down.
SaxendaUsed with diet and activity, this treatment is for weight loss and for keeping the weight off over the long term. It is for adults and for children 12 and older (over 60 kg) who have obesity. It is also for adults who have overweight and a weight-related condition.

FDA labels appear on DailyMed: 1 2.

What is different for seniors?

Older adults: liraglutide label details
What changesWhat the label saysLabels
HypoglycemiaTaking it with insulin or a sulfonylurea makes low blood sugar more likely, so those doses may need lowering.All of them
Acute Kidney Injury Due to Volume DepletionKidney injury can occur when vomiting or diarrhea causes fluid loss. Drink fluids and report heavy fluid loss.All of them
Heart Rate IncreaseCan raise resting heart rate. If your heart races or pounds while you are at rest, tell your doctor.Saxenda
Taken with insulin or sulfonylureasThe risk of low blood sugar goes up if you take insulin or a sulfonylurea with this medicine. Sulfonylureas include glipizide or glimepiride. Your doctor may reduce those doses.All of them

According to the FDA label (DailyMed): 1 2.

According to the label warnings: FDA DailyMed label.

Coverage for seniors

Medicare Part D can cover these medicines when they are prescribed for diabetes or cardiovascular disease.

Part D plans may cover a GLP-1 when it is prescribed to treat type 2 diabetes, moderate to severe sleep apnea, or fatty liver disease.

Medicare Part D does not cover a GLP-1 when it is used only for weight loss.

Where Medicaid covers weight-loss GLP-1s, prior authorization is generally required.

Sources: humana.com, medicare.gov, KFF.

Alternatives for seniors

GLP-1 medicines and older adults
MedicineFor older adultsHow it is takenTrial result
SaxendaApproved uses applydaily injectionNot listed
VictozaApproved uses applydaily injectionNot listed
OzempicApproved uses applyweekly injectionNot listed
WegovyApproved uses applyweekly injection or daily tablet6.5% for a heart attack, stroke, or death tied to heart disease
RybelsusApproved uses applydaily tabletstroke, heart attack or death from heart disease: 12%
MounjaroApproved uses applyweekly injectionNot listed
ZepboundApproved uses applyweekly injectionNot listed
FoundayoApproved uses applydaily tabletNot listed
TrulicityApproved uses applyweekly injectionstroke, heart attack or death from heart disease: 12%
ByettaApproved uses applytwice-daily injectionNot listed

Sources: FDA label (DailyMed), PubMed.

Questions for your prescriber